Sanofi
COMBINATION THERAPIES AGAINST CANCER TARGETING CD38 AND TGF-BETA
Last updated:
Abstract:
The present disclosure relates to combination cancer therapies targeting CD38 and TGF-.beta. using antibodies specific for these targets. Also provided are compositions useful in the therapies.
Status:
Application
Type:
Utility
Filling date:
10 Jul 2019
Issue date:
27 May 2021